BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30241562)

  • 1. Xue-Fu-Zhu-Yu capsule in the treatment of qi stagnation and blood stasis syndrome: a study protocol for a randomised controlled pilot and feasibility trial.
    He H; Chen G; Gao J; Liu Y; Zhang C; Liu C; Li H; He Q; Li J; Wang J
    Trials; 2018 Sep; 19(1):515. PubMed ID: 30241562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of Suxiao Jiuxin Pill in the treatment of stable angina (Qi stagnation and blood stasis syndrome): study protocol of a randomized, double-blind, placebo-controlled, multi-center clinical trial.
    Ruan X; Li Y; Sun Y; Jia M; Xu X; Huo L; Song W; Yao Y; Wang X
    Trials; 2021 Jul; 22(1):466. PubMed ID: 34281600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial for gualou danshen granules in the treatment of unstable angina pectoris patients with phlegm-blood stasis syndrome.
    Guo J; Dai S; Ding Y; He H; Zhang H; Dan W; Qin K; Wang H; Li A; Meng P; Li S; He Q
    Medicine (Baltimore); 2020 Aug; 99(33):e21593. PubMed ID: 32872012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive Biomarker Analysis of Xue-Fu-Zhu-Yu Capsule for Patients with Qi Stagnation and Blood Stasis Pattern: A Nested Case-Control Study.
    Chen G; He H; Hu K; Gao J; Li J; Han M; Wang J
    Evid Based Complement Alternat Med; 2019; 2019():7182865. PubMed ID: 31827557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of Xinnaoning capsule in treating chronic stable angina (qi stagnation and blood stasis syndrome): Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
    Zhao JN; Zhang Y; Lan X; Chen Y; Li J; Zhang P; Wu LQ; Jia ST; Liu Y; Xu FQ
    Medicine (Baltimore); 2019 Aug; 98(31):e16539. PubMed ID: 31374015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of Chinese herbal medicine Shen-Qi Hua-Yu formula in patients with diabetic lower extremity artery disease: Study protocol of a multi-center, randomized, double-blind, placebo-controlled trial.
    Leng Y; Gao H; Fu X; Xie H; Hu Z; Zhu J; Liu X; Zhou X; Xie Z; Xie C
    Medicine (Baltimore); 2020 Jan; 99(3):e18713. PubMed ID: 32011447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UPLC-QTOF/MS-based metabolomics analysis of plasma reveals an effect of Xue-Fu-Zhu-Yu capsules on blood-stasis syndrome in CHD rats.
    Zhao Y; Nie S; Yi M; Wu N; Wang W; Zhang Z; Yao Y; Wang D
    J Ethnopharmacol; 2019 Sep; 241():111908. PubMed ID: 31029757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
    Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
    Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of Jiedu Tongluo granules for treating post-stroke depression with qi deficiency and blood stasis syndrome: study protocol for a randomized controlled trial.
    Zhao AM; Qiu WR; Mao LJ; Ren JG; Xu L; Yao MJ; Bilinksi K; Chang D; Liu JX
    Trials; 2018 May; 19(1):275. PubMed ID: 29747670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of Chinese herbal medicine Qirui Weishu capsule in treating chronic non-atrophic gastritis: A multicentre, double-blind, randomized controlled clinical trial.
    Chen HF; Gong Y; Huang Z; Zhao G; Chen ZM; Zen YM; Li HZ; Hu YL
    J Ethnopharmacol; 2022 Aug; 294():115341. PubMed ID: 35551978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of Jian-Wei-Qu-Tong Pills for the treatment of chronic non-atrophic gastritis (spleen and stomach qi deficiency with damp-heat stasis syndrome): study protocol for a phase II, randomized controlled trial.
    Zhang XX; Chen WW; She B; Luo RJ; Shi N; Xue P; Yang XN; Xia Q
    Trials; 2014 Jul; 15():272. PubMed ID: 25002101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanxinjing capsule in the treatment of chronic stable angina: study protocol for a randomized controlled trial.
    Tian Y; Zhang J; Zhao Y; Mao J; Zhu L; Gao R; Wang X; Zhu M; Ma L; Zhao M; Zheng W
    Trials; 2018 Oct; 19(1):577. PubMed ID: 30342551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of fire needle therapy for blood stasis syndrome of plaque psoriasis: protocol for a randomized, single-blind, multicenter clinical trial.
    Liu L; Lu Y; Yan XN; Yang SQ; Gong LP; Li LE; Zhao YD; Yin QF; Wang RP; An YP; Huang G; Zhang JF; Sun XY; Li X; Li B
    Trials; 2020 Aug; 21(1):739. PubMed ID: 32843084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effectiveness of Qilong capsule in patients with ischemic stroke: A prospective, multicenter, non-randomized controlled trial.
    Lyu J; Gao Y; Wei R; Cai Y; Shen X; Zhao D; Zhao X; Xie Y; Yu H; Chai Y; Xie Y
    Phytomedicine; 2022 Sep; 104():154278. PubMed ID: 35780589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of Xiaopi Yishen herbal extract granules in treatment of fatigue-predominant subhealth due to liver-qi stagnation and spleen-qi deficiency: a prospective, randomized, placebo-controlled and double-blind clinical trial].
    Wang TF; Xue XL; Zhang YJ; Han P; Li Z; Wang WP; Xing JM; Wang QB; Tang Y; Li L; Wang JJ; Li GR; Ji SL; Wu LX; Zhao Y; Wu XY; Zhao RS
    Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):515-24. PubMed ID: 21565137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral traditional Chinese medication for adhesive small bowel obstruction.
    Suo T; Gu X; Andersson R; Ma H; Zhang W; Deng W; Zhang B; Cai D; Qin X
    Cochrane Database Syst Rev; 2012 May; (5):CD008836. PubMed ID: 22592734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics study on the therapeutic effect of traditional Chinese medicine Xue-Fu-Zhu-Yu decoction in coronary heart disease based on LC-Q-TOF/MS and GC-MS analysis.
    Yi M; Li Q; Zhao Y; Nie S; Wu N; Wang D
    Drug Metab Pharmacokinet; 2019 Oct; 34(5):340-349. PubMed ID: 31474470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of comparative effectiveness research for similar Chinese patent medicine for angina pectoris of coronary heart disease: a new approach based on patient-important outcomes.
    Cao H; Zhai J; Mu W; Lei X; Cao H; Liu C; Shang H
    Trials; 2014 Mar; 15():84. PubMed ID: 24641790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Fang R; Hu H; Zhou Y; Wang S; Mei Z; She R; Peng X; Jiang Q; Wang X; Xie L; Lin H; Meng P; Zhang K; Wang W; Xie Y; Liu L; Tong J; Wu D; Luo Y; Liu C; Lu Y; Yu S; Cheng S; Xu L; Fang Z; Shang H; Ge J
    Front Pharmacol; 2022; 13():967457. PubMed ID: 36686705
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of Hou Gu Mi Xi in patients with spleen qi deficiency syndrome who underwent radical gastrectomy for gastric cancer: protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
    Zhou X; Yan DM; Zhu WF; Liu WJ; Nie HY; Xu S; Jiang YP; Zhang KH; Fu Y; Wan YY; Yu XY; Li H; Sun X; Chen XF
    Trials; 2019 Jun; 20(1):343. PubMed ID: 31182140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.